DE2733578A1 - Intravenoese mittel, verfahren zu deren herstellung sowie deren verwendung - Google Patents

Intravenoese mittel, verfahren zu deren herstellung sowie deren verwendung

Info

Publication number
DE2733578A1
DE2733578A1 DE19772733578 DE2733578A DE2733578A1 DE 2733578 A1 DE2733578 A1 DE 2733578A1 DE 19772733578 DE19772733578 DE 19772733578 DE 2733578 A DE2733578 A DE 2733578A DE 2733578 A1 DE2733578 A1 DE 2733578A1
Authority
DE
Germany
Prior art keywords
acid
nutrient
solution
dextrose
sugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772733578
Other languages
German (de)
English (en)
Inventor
Roger Lee Stone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of DE2733578A1 publication Critical patent/DE2733578A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19772733578 1976-07-28 1977-07-26 Intravenoese mittel, verfahren zu deren herstellung sowie deren verwendung Withdrawn DE2733578A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70934276A 1976-07-28 1976-07-28

Publications (1)

Publication Number Publication Date
DE2733578A1 true DE2733578A1 (de) 1978-02-02

Family

ID=24849460

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772733578 Withdrawn DE2733578A1 (de) 1976-07-28 1977-07-26 Intravenoese mittel, verfahren zu deren herstellung sowie deren verwendung

Country Status (8)

Country Link
JP (1) JPS5350318A (enExample)
BE (1) BE857264A (enExample)
DE (1) DE2733578A1 (enExample)
FI (1) FI772310A7 (enExample)
FR (1) FR2359609A1 (enExample)
GB (1) GB1582992A (enExample)
NL (1) NL7708308A (enExample)
SE (1) SE7708657L (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004110425A1 (de) * 2003-06-12 2004-12-23 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Verwendung von sorbinsäure zur vermeidung von bakteriellen infektionen und als leistungsförderer bei tieren

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2126082A (en) * 1982-08-12 1984-03-21 Heinrich Schulze Pharmaceutical preparations having analgetic and cytostatic activity
GB8603621D0 (en) * 1986-02-14 1986-03-19 Habib N Modifying lipid structure of cell membranes
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
ES2523018T3 (es) * 2004-06-30 2014-11-20 Nutrition Sciences N.V./S.A. Ácidos grasos de cadena media aplicables como agentes anti-microbianos
US8747882B2 (en) 2005-04-21 2014-06-10 Astra Tech Ab Catheter assembly with bactericidal effect

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2466663A (en) * 1944-10-20 1949-04-05 Ward Baking Co Fungicide containing caprylic acid and its salt

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2466663A (en) * 1944-10-20 1949-04-05 Ward Baking Co Fungicide containing caprylic acid and its salt

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Lexikon der Hilfstoffe, Fiedler, 1971, S. 99 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004110425A1 (de) * 2003-06-12 2004-12-23 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Verwendung von sorbinsäure zur vermeidung von bakteriellen infektionen und als leistungsförderer bei tieren

Also Published As

Publication number Publication date
FI772310A7 (enExample) 1978-01-29
FR2359609B1 (enExample) 1981-01-09
SE7708657L (sv) 1978-01-29
JPS5350318A (en) 1978-05-08
NL7708308A (nl) 1978-01-31
FR2359609A1 (fr) 1978-02-24
GB1582992A (en) 1981-01-21
BE857264A (fr) 1978-01-30

Similar Documents

Publication Publication Date Title
US4489097A (en) Intravenous solutions with antimicrobial agent
EP1206281B1 (de) Formulierung enthaltend moxifloxacin und natriumchlorid
DE3686718T2 (de) Fluessigkeitstherapie mit 1-laktat- und/oder pyruvat-anionen.
DE2513797C2 (de) Pharmazeutische zusammensetzung
DE69528714T2 (de) Propofol und disodium edta enthaltende öl-in-wasser emulsionen
EP0243867B1 (de) Mittel zur Verabreichung von Hyaluronsäure an Säuger
DE3686221T2 (de) Emulsionen zur parenteralen und/oder oralen verabreichung schwer wasserloeslicher ionisierbarer hydrophober arzneistoffe.
DE69008729T2 (de) Verfahren zur herstellung einer öl-in-wasser-emulsion eines wirkstoffes.
EP0337420A2 (de) Dialysier- und Spüllösung für die intraperitoneale Verabreichung mit antimikrobieller Ausrüstung
EP1206244B1 (de) Wässrige arzneimittelformulierung von moxifloxacin oder salzen davon
DE2414593A1 (de) Arzneimittel und verfahren zu seiner herstellung
DE2923144C2 (de) Impfstoff zur Prophylaxe und Behandlung von durch Trichophyton mentagrophytes hervorgerufenen Trichophytien bei Pelztieren und Kaninchen und seine Herstellung
DE3418820C2 (enExample)
DE3115080A1 (de) Arzneimittel fuer die orale verabreichung und verfahren zu seiner herstellung
DE2733578A1 (de) Intravenoese mittel, verfahren zu deren herstellung sowie deren verwendung
EP2076243B1 (de) Flüssigformulierung von g-csf
DE60124516T2 (de) Kombination des lezithins mit ascorbinsäure
DE3505572C2 (enExample)
CA1098039A (en) Intravenous solutions with antimicrobial agent
DE69315840T2 (de) Verfahren zur verabreichung einer lösung von granulozyten-kolonie-stimulierendem faktor
DE1086012B (de) Verfahren zur Herstellung von protrahiert wirkenden Vitamin-B-Praeparaten
DE60203895T2 (de) Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie
DE3104282C2 (enExample)
RU2320352C2 (ru) Способ лечения субклинического мастита у коров
DE446130C (de) Verfahren zur Haltbarmachung von der Gaerung oder Faeulnis unterworfenen Stoffen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8130 Withdrawal